EASL SLD Summit 2027	204 days
	EASL Steatotic Liver Disease Summit 2/10/2027 - 2/13/2027 Venue: Berlin, Berlin, Germany
Please note ! All dates are subject to changes.

The EASL Steatotic Liver Disease Summit 2027 is a three-day translational meeting that follows steatotic liver disease across its full continuum - from population policy to the patient in clinic, and from tissue microenvironment to the single stressed hepatocyte and its organelles. Across ten thematic sessions, three State-of-the-Art lectures, a dedicated best-abstract session, and eight ePoster sessions, the programme deliberately refuses to separate "basic" from "clinical." The same disease spectrum - MASLD, MetALD and ALD, is interrogated at every scale by epidemiologists, hepatologists, pathologists, and cell and mechano-biologists. The premise is that SLD is now a public-health problem with unresolved mechanistic and methodological foundations. The SLD Summit therefore pairs the field's most pressing questions (Has renaming the disease changed anything? Can a liver stiffness score predict outcomes? Can we still justify placebo arms?) with the biological and mechanistic insights that underpin these debates and will shape future answers. Designed for all stakeholders in the SLD community, from clinicians to translational and basic scientists, the SLD Summit provides a comprehensive update on the latest evidence, emerging data, and key developments across the field. It brings together both the policy headlines and the molecular mechanisms that drive them, reflecting the growing recognition that progress in SLD depends on understanding the connections between clinical practice, research, and biology. Website: https://easl.eu/event/easl-sld-summit-2027/

Organizers
	EASL - European Association for the Study of the Liver
	Home of Hepatology 7 rue Daubin 1203, Geneva Switzerland Tel: +41-(0)22-807 03 60 http://www.easl.eu/

PC Version	About Us
Showseye - Global Professional Events